Citadel Advisors - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is and the CUSIP is 800677956. A total of 4 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q2 2016$160,000
+21.2%
27,600
+26.0%
0.00%
Q1 2016$132,000
-53.4%
21,900
-29.4%
0.00%
Q4 2015$283,000
+40.8%
31,000
-13.2%
0.00%
Q3 2015$201,000
-21.2%
35,700
+55.2%
0.00%
Q2 2015$255,000
+11.4%
23,000
+57.5%
0.00%
Q1 2015$229,000
-58.5%
14,600
-59.8%
0.00%
-100.0%
Q4 2014$552,000
+49.2%
36,300
+5.8%
0.00%
Q3 2014$370,000
-19.2%
34,300
+14.3%
0.00%
-100.0%
Q2 2014$458,000
-46.2%
30,000
-36.3%
0.00%0.0%
Q1 2014$852,000
+17.5%
47,100
-9.8%
0.00%0.0%
Q4 2013$725,000
+127.3%
52,200
+71.7%
0.00%
Q3 2013$319,000
+138.1%
30,400
+77.8%
0.00%
Q2 2013$134,00017,1000.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2014
NameSharesValueWeighting ↓
LUPO SECURITIES, LLC 38$18,0000.14%
GROUP ONE TRADING, L.P. 51,600$291,0000.00%
SIMPLEX TRADING, LLC 35$37,0000.00%
Citadel Advisors 35,700$201,0000.00%
View complete list of SANGAMO THERAPEUTICS INC shareholders